17179-91-8

Basic information

• Product Name: 2,3-DIMETHYLGLUTARIC ACID
• Synonyms: 2,3-DIMETHYLGLUTARIC ACID;LQNGULJVMSGMOE-UHFFFAOYSA-N
• CAS NO: 17179-91-8
• Molecular Formula: C₇H₁₂O₄
• Molecular Weight: 160.17
• Mol File: 17179-91-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 300.4°Cat760mmHg
• Flash Point: 149.7°C
• Appearance: /
• Density: 1.194g/cm³
• Vapor Pressure: 0.000264mmHg at 25°C
• Refractive Index: 1.471
• CAS DataBase Reference: 2,3-DIMETHYLGLUTARIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-DIMETHYLGLUTARIC ACID(17179-91-8)
• EPA Substance Registry System: 2,3-DIMETHYLGLUTARIC ACID(17179-91-8)

Safety Data

• Hazardous Substances Data: 17179-91-8(Hazardous Substances Data)

Usage

Type of compound

dicarboxylic acid (contains two carboxylic acid functional groups)

Physical form

white crystalline solid

Solubility

soluble in water and organic solvents

Uses

intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds; production of food additives, flavorings, and fragrances; potential applications in materials science and as a building block for the synthesis of novel polymers and materials.

InChI:InChI=1/C7H12O4/c1-4(3-6(8)9)5(2)7(10)11/h4-5H,3H2,1-2H3,(H,8,9)(H,10,11)

Upstream product

• 873988-72-8 2-methyl-butane-1,1,3-tricarboxylic acid 
• 876504-08-4 2-hydroxy-2,3-dimethyl-glutaric acid 
• 858834-81-8 2-methyl-butane-1,3,3-tricarboxylic acid 
• 10034-85-2 hydrogen iodide 
• 64-17-5 ethanol 
• 34611-32-0 2-cyano-3,4-dimethyl-glutaric acid diethyl ester 
• 151-50-8 potassium cyanide 
• 903639-00-9 2-cyano-2,3-dimethyl-glutaric acid 
• 623-70-1 ethyl (E)-crotonate 
• 609-08-5 Diethyl methylmalonate 
• 17225-74-0 N-(2-Hydroxy-ethyl)-N-methyl-propionamide 
• 623-43-8 crotonic acid methyl ester 
• 107932-60-5 (S)-N-methyl-N-propionylvalinol 
• 74036-66-1 (S)-(-)-prolinol propionamide 

Downstream Products

• 110-15-6 succinic acid 

Relevant articles and documents

Urea compounds as inhibitors for vla-4

A compound of formula (I) where D is a VLA-4 specificity determinant which does not impart significant IIB/IIIa activity; R41 is a group of the formula (V): U - (CH2)d - V - T wherein U is selected from oxygen, sulphur, a direct bond or —CH2O—, V is selected from nitrogen, oxygen, sulphur, S(O), S(O)2 or a direct bond, d is zero or a number from 1 to 4, and T is selected from a range of variables defined in the application; and other variables are defined in the application, or a pharmaceutically acceptable salt or in vivo hydrolysable derivative thereof. The compounds are useful in the treatment of disease mediated by the interaction between VCAM-1 and/or fibronectin and the integrin receptor α4β1. Pharmaceutical compositions and methods of use or treatment are also described and claimed.

A DIASTEREO- AND ENANTIOSELECTIVE MICHAEL ADDITION OF CHIRAL AMIDE ENOLATES TO α,β-UNSATURATED ESTERS; A STEREOSELECTIVE SYNTHESIS OF (+)-DEHYDROIRIDODIOL AND (-)-ISODEHYDROIRIDODIOL

(+)-Dehydroiridodiol and (-)-isodehydroiridodiol were synthesized stereoselecticely using the diastereo- and enantioselective Michael addition of chiral amide enolates to α,β-unsaturated esters.